Abstract:Matrix metalloproteinases (MMPs) are proteolytic enzymes that play critical roles in the pathogenesis of human cancers. Clinical trials using synthetic small molecule MMP inhibitors have been carried out but with little success. Tissue inhibitors of metalloproteinases (TIMPs) are endogenous inhibitors that block the extracellular matrix-degrading activity of MMPs. Here, we investigated the possibilities of genetically modifying human bones with TIMPs to create a high-TIMP bone microenvironment, which is hostile to metastatic prostate cancer cells using adenovirus-mediated gene transfer technology and SCID-hu end-organ colonization mouse model. Two strategies were used to achieve bone-specific TIMP expression: (i) ex vivo bone adenoviral infection followed by in vivo bone implantation; and (ii) ex vivo BMS cell infection followed by injection into in vivo implanted human fetal bones. PC-3 prostate cancer cells were injected into human fetal bones 4 weeks after implantation in SCID mice. In vitro, adenovirus-mediated expression of TIMP-1 or TIMP-2 in bone fragments inhibited MMP-2 activity, bone turnover and prostate cancer cell-induced proteolytic degradation as determined by gelatin zymography, calcium measurement and DQ protein quenched fluorescence assay, respectively. In vivo, immunohistochemistry confirmed TIMP-2 expression in AdTIMP-2-infected bone implants 4 weeks after implantation in SCID mice. Mice receiving AdTIMP-treated bone fragments showed significantly reduced PC-3-induced osteolysis, osteoclast recruitment and bone turnover in the implanted bones. We propose that adenoviral gene transfer of TIMP-1 and TIMP-2 can prevent the proteolytic activity of prostate cancer cells in bone and that enhancing antiproteolytic defense mechanisms in target organs represents a promising form of prostate cancer gene therapy. (C) 2007 Wiley-Liss, Inc.

Inhibition of tumor growth and induction of apoptosis in prostate cancer cell lines by overexpression of tissue inhibitor of matrix metalloproteinase-3

Cloning and Expression of the Cdna Encoding Human Tissue Inhibitor of Metalloproteinase-3 and Its Inhibition on Angiogenesis

Tissue inhibitor of metalloproteinases-3 transfer suppresses malignant behaviors of colorectal cancer cells

Adenovirus-Mediated Expression Of Timp-1 And Timp-2 In Bone Inhibits Osteolytic Degradation By Human Prostate Cancer

Expression and Inhibitory Role of TIMP-3 in Hepatocellular Carcinoma.

Prognostic Value of T Cell Immunoglobulin Mucin-3 in Prostate Cancer.

TIMP3 Regulates Osteosarcoma Cell Migration, Invasion, and Chemotherapeutic Resistances

Recombinant Tissue Metalloproteinase Inhibitor-3 Protein Induces Apoptosis of Murine Osteoblast MC3T3-E1

Recombinant protein of tissue inhibitor of metalloproteinase-3 induces apoptosis of mouse MC3T3-E1 osteoblasts

Modulation of peritumoral fibroblasts with a membrane-tethered tissue inhibitor of metalloproteinase (TIMP) for the elimination of cancer cells

TIMP-3 Expression Associates with Malignant Behaviors and Predicts Favorable Survival in HCC.

Tissue Inhibitor of Matrix Metalloproteinase-1 Suppresses Apoptosis of Mouse Bone Marrow Stromal Cell Line MBA-1

TIMP-3 acts as suppressor gene in hepatocarcinoma

Prokaryotic expression,purification and characterization of tissue inhibitor of metalloproteinase-2

Roles of MMPs and TIMPs in invasion and metastasis of prostate carcinoma

TIMP-1 mediates the inhibitory effect of interleukin-6 on the proliferation of a hepatocarcinoma cell line in a STAT3-dependent manner.

[Overexpression of Human Tumor Metastasis-Related Gene TMSG-1 Suppresses Cell Proliferation and Invasion of a Highly Metastatic Prostate Cancer Cell Line PC-3M-1E8 in Vitro].

Analysis of Tim-3 As a Therapeutic Target in Prostate Cancer

[Adenovirus-Delivered Tissue Inhibitor of Metalloproteinases-3 Transfection Increases the Sensitivity of Cervical Cancer Cells to Cisplatin].

Integrin α7 binds tissue inhibitor of metalloproteinase 3 to suppress growth of prostate cancer cells.

Regulating the Transcription and Expression of Matrix Metalloproteinase-9(MMP9)and the Tissue Inhibitor of Metalloproteinase 1(TIMP1) with Stat3